Healthy volunteers needed for early safety test of experimental drug
NCT ID NCT06575400
First seen Apr 02, 2026 · Last updated Apr 29, 2026 · Updated 7 times
Summary
This early-stage trial tests the safety and how the body handles a new drug called BI 3804379 in 106 healthy adults. Participants receive either the drug or a placebo as a single or repeated injection under the skin. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SGS Life Science Services - Clinical Research
RECRUITINGEdegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.